DXCM Dexcom PE ratio, current and historical analysis
As of Nov 21, 2024, the Dexcom stock's P/E ratio is 42.79. This takes into account the latest EPS of $1.74 and stock price of $74.46. The PE ratio has decreased by 38% from its last 4 quarters average of 69.4.
DXCM PE ratio history
The PE ratio of Dexcom has averaged 130.88 over the last seven years. The current price-to-earnings ratio of 42.79 is 67% less than the historical average. Analyzing the last seven years, DXCM's PE ratio reached its highest point in the Sep 2018 quarter at 298, when the price was $35.76 and the EPS was $0.12. The lowest point was recorded in the Sep 2024 quarter, when it reached 38.53 with a price of $67.04 and an EPS of $1.74.
Dexcom PE ratio by year
Maximum annual increase: 278.63% in 2021
Maximum annual decrease: -67.58% in 2020
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 88.64 | -31.12% |
| 2022 | 128.68 | -46.32% |
| 2021 | 239.71 | 278.63% |
| 2020 | 63.31 | -67.58% |
| 2019 | 195.3 | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
DXCM average PE ratio chart
DXCM's current PE ratio is under its 3, 5 and 10-year averages.
DXCM PE vs peers
DXCM's PE ratio is less than its peer stocks BDX and WST, but it is above JNJ's and ABT's. Dexcom's current PE ratio of 42.79 is more than the average of its peers, which is 32.25.
| Stock name | PE ratio | Market cap |
|---|---|---|
| EW Edwards Lifesciences Corp | 10.14 | $41.51B |
| JNJ Johnson & Johnson | 25.79 | $374.39B |
| MDT Medtronic plc | 28.44 | $108.68B |
| ABT Abbott Laboratories | 35.53 | $203.38B |
| DXCM Dexcom Inc | 42.79 | $29.08B |
| BDX Becton Dickinson & Co | 46.48 | $65.16B |
| WST West Pharmaceutical Services Inc | 47.12 | $23.24B |
| TNDM Tandem Diabetes Care Inc | N/A | $2.02B |
| QDEL Quidel Corp | N/A | $2.55B |
Frequently asked questions
What is Dexcom's PE ratio?
The price to earnings ratio for DXCM stock is 42.79 as of Nov 21, 2024.
What is the 3-year average PE ratio for Dexcom (DXCM)?
As an average over the last 3 years, DXCM stock has a PE ratio of 122.93.
What is the 5-year average PE ratio for Dexcom (DXCM)?
As an average over the last 5 years, DXCM stock has a PE ratio of 122.52.
What is the highest PE ratio for DXCM?
Over the last seven years, the quarterly PE ratio reached its highest level at 298 in the Sep 2018 quarter.
How does the current PE ratio for DXCM compare to its historical average?
DXCM's price to earnings ratio is currently 67% below its 7-year historical average.
How is DXCM's PE ratio calculated (Dexcom PE ratio formula)?
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Nov 21, 2024), Dexcom's share price is $74.46. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.74. Therefore, Dexcom's price to earnings ratio for today is 42.79. PE RATIO(42.79) = STOCK PRICE($74.46) / TTM EPS($1.74)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.